Unveiling Novel Antibodies and Their Practical Implication in RMDs - Report from EULAR 2026

Dr. Diane van der Woude provides a fascinating expert overview of the discovery of novel autoantibodies and their clinical translation in rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap highlights the latest breakthroughs in biomarker identification, how these emerging antibody profiles refine early diagnosis and risk stratification, and their practical implications for guiding highly targeted, personalized treatment pathways.Video: https://medicaldigest.org/scientific-contents/interview:unveiling-novel-antibodies-and-their-practical-implication-rmds